← Open Payments lookup

MAHEALANI ROACH: Open Payments

NPI 1649730292 · POWHATAN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,735 in 83 payments from 21 companies in 2025. Trend: 2023 $1,731 · 2024 $1,504 · 2025 $1,735

Food & beverage: $1,735
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP13$266
ABBVIE INC.15$259
Amgen Inc.12$244
PFIZER INC.10$161
Eisai Inc.1$125
Lilly USA, LLC8$121
TMS NeuroHealth Centers Inc.1$97
Novo Nordisk Inc4$72
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$51
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$47

Products named: REPATHA, QULIPTA, Leqembi, FARXIGA, OTEZLA, NURTEC ODT, MOUNJARO, TMS NeuroHealth Centers Inc..

Industry payments across VA — which companies pay providers there.